AAICare®
AAICare® diagnoses AMR rapidly and comprehensively.
Pathogen quantification, AMR diagnosis, comprehensive reports, genomic surveillance, improved outcomes.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial stewardship
- Microbial diagnostics
- Infection prevention
- Antimicrobial compound/strategy
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Yeasts
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Validation
- Research
- Development
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- Co-develop
- Joint Venture
- License
- Outsource
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Clinical or academic clients with clinical samples requiring genomic analysis
AarogyaAI®: Precise antimicrobial diagnosis at point-of-care using genomics and AI, reducing infections and combating pandemics.
AAICare®-TB AAICare®-Candida AAICare®-Salmonella AAICare®-Neisseria gonorrhoeae
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!